Skip to main content
TipRanks
Go Ultimate75% OFF

Imagion Biosystems Ltd. (IBX) Ratios

18 Followers

Imagion Biosystems Ltd. Ratios

AU:IBX's free cash flow for Q2 2026 was AU$-1.79M. For the 2026 fiscal year, AU:IBX's free cash flow was increased by AU$0.00 and operating cash flow was AU$-1.79M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.480.550.122.8817.74
Quick Ratio0.480.550.122.7017.52
Cash Ratio0.440.530.042.5717.26
Solvency Ratio-1.02-0.40-1.35-1.64-6.94
Operating Cash Flow Ratio-0.96-0.25-1.62-5.02-6.53
Short-Term Operating Cash Flow Coverage-1.60-0.45-4.89-8.36-334.75
Net Current Asset ValueAU$ -2.17MAU$ -2.30MAU$ -7.77MAU$ -309.58KAU$ 12.96M
Leverage Ratios
Debt-to-Assets Ratio1.251.021.320.460.00
Debt-to-Equity Ratio-1.19-1.25-1.590.980.00
Debt-to-Capital Ratio6.375.052.680.500.00
Long-Term Debt-to-Capital Ratio0.000.00-0.250.000.00
Financial Leverage Ratio-0.95-1.23-1.212.131.06
Debt Service Coverage Ratio-1.05-0.07-2.39-7.01-130.82
Interest Coverage Ratio-4.23-0.66-13.86-69.63-1063.24
Debt to Market Cap0.362.700.230.040.00
Interest Debt Per Share0.010.090.240.170.00
Net Debt to EBITDA-0.20-0.25-0.56-0.012.38
Profitability Margins
Gross Profit Margin0.00%84.95%-25.84%-663.76%-1061.20%
EBIT Margin0.00%-28.05%-1060.84%-2562.97%-2585.36%
EBITDA Margin0.00%-26.27%-951.58%-2328.90%-2411.68%
Operating Profit Margin0.00%-28.39%-1443.74%-2564.09%-3570.53%
Pretax Profit Margin0.00%-93.96%-1478.20%-2071.53%-2587.21%
Net Profit Margin0.00%-77.56%-1151.86%-2071.95%-2587.21%
Continuous Operations Profit Margin0.00%-77.56%-1151.86%-2071.53%-2587.21%
Net Income Per EBT99.07%82.54%77.92%100.02%100.00%
EBT Per EBIT121.35%331.01%102.39%80.79%72.46%
Return on Assets (ROA)-210.82%-73.72%-271.98%-98.33%-42.68%
Return on Equity (ROE)199.33%90.54%329.30%-209.71%-45.28%
Return on Capital Employed (ROCE)165.82%33.14%2886.49%-147.27%-62.33%
Return on Invested Capital (ROIC)-882.39%-110.65%-540.51%-87.59%-35.23%
Return on Tangible Assets-210.82%-73.72%-271.98%-98.33%-42.68%
Earnings Yield-62.12%-199.95%-115.27%-36.45%-7.57%
Efficiency Ratios
Receivables Turnover0.003008.0514.705.127.43
Payables Turnover0.010.193.3011.126.31
Inventory Turnover0.000.000.0011.4715.49
Fixed Asset Turnover0.00145.840.270.090.67
Asset Turnover0.000.950.240.050.02
Working Capital Turnover Ratio0.00-0.78-1.700.060.02
Cash Conversion Cycle-49528.57-1887.74-85.7170.2814.88
Days of Sales Outstanding0.000.1224.8471.2949.13
Days of Inventory Outstanding0.000.000.0031.8123.56
Days of Payables Outstanding49528.571887.86110.5432.8157.81
Operating Cycle0.000.1224.84103.1072.69
Cash Flow Ratios
Operating Cash Flow Per Share-0.01-0.03-0.27-0.31-0.19
Free Cash Flow Per Share-0.01-0.03-0.28-0.33-0.20
Dividend Paid and CapEx Coverage Ratio-1010926.00-1270611.00-43.68-17.15-23.16
Capital Expenditure Coverage Ratio-1010926.00-1270611.00-43.68-17.15-23.16
Operating Cash Flow Coverage Ratio-1.58-0.45-1.38-1.89-110.14
Operating Cash Flow to Sales Ratio0.00-0.48-7.68-18.38-21.77
Free Cash Flow Yield-58.29%-122.92%-78.60%-34.22%-6.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.61-0.50-0.87-2.74-13.21
Price-to-Sales (P/S) Ratio0.000.399.9956.84341.88
Price-to-Book (P/B) Ratio-3.21-0.45-2.865.755.98
Price-to-Free Cash Flow (P/FCF) Ratio-1.72-0.81-1.27-2.92-15.06
Price-to-Operating Cash Flow Ratio-1.72-0.81-1.30-3.09-15.71
Price-to-Earnings Growth (PEG) Ratio0.020.01-0.05-0.050.64
Enterprise Value Multiple-2.14-1.73-1.61-2.46-11.80
Enterprise Value7.65M1.21M16.63M27.07M66.26M
EV to EBITDA-2.14-1.73-1.61-2.46-11.80
EV to Sales0.000.4515.3657.18284.56
EV to Free Cash Flow-1.89-0.95-1.96-2.94-12.53
EV to Operating Cash Flow-1.89-0.95-2.00-3.11-13.07
Tangible Book Value Per Share-0.01-0.05-0.120.170.51
Shareholders’ Equity Per Share-0.01-0.05-0.120.170.51
Tax and Other Ratios
Effective Tax Rate0.010.170.220.260.43
Revenue Per Share0.000.060.040.020.01
Net Income Per Share-0.02-0.05-0.41-0.35-0.23
Tax Burden0.990.830.781.001.00
Interest Burden1.213.351.390.811.00
Research & Development to Revenue0.000.154.857.6411.61
SG&A to Revenue0.000.983.3111.6516.14
Stock-Based Compensation to Revenue0.000.000.431.382.14
Income Quality0.940.610.670.890.84

Currency in AUD